Cargando…
Immunotherapies in Huntington's disease and α-Synucleinopathies
Modulation of immune activation using immunotherapy has attracted considerable attention for many years as a potential therapeutic intervention for several inflammation-associated neurodegenerative diseases. However, the efficacy of single-target immunotherapy intervention has shown limited or no ef...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052383/ https://www.ncbi.nlm.nih.gov/pubmed/32161599 http://dx.doi.org/10.3389/fimmu.2020.00337 |